[
    [
        {
            "time": "2020-03-15",
            "original_text": "Canada giving AbCellera Biologics C$176 mln for coronavirus research",
            "features": {
                "keywords": [
                    "Canada",
                    "AbCellera",
                    "Biologics",
                    "C$176 mln",
                    "coronavirus",
                    "research"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Canada giving AbCellera Biologics C$176 mln for coronavirus research",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]